Breaking News

GSK Integrates Oncology R&D

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

GlaxoSmithKline has formed GSK Oncology, a newly integrated Oncology R&D Organization. GSK Oncology unites small discovery units (DPUs) within the existing Centre of Excellence for Drug Discovery (CEDD), and a highly specialized drug development group to create a dedicated oncology R&D organization, led by Paolo Paoletti, M.D., senior vice president Oncology R&D. “GSK has designed this new organization to help us increase the breadth and depth of our core oncology knowledge, in o...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters